• Profile
Close

Endocrine dysfunction following immune checkpoint inhibitor therapy

Current Opinion in Endocrinology, Diabetes and Obesity Sep 08, 2017

Konda B, et al. - In this case-based review, the physicians intended to present clinical presentation, diagnosis, and management strategies of immune-related endocrinopathies associated with immune checkpoint inhibitors use. The results of this study displayed that immune checkpoint inhibitors use is associated with serious endocrinopathies that may have a nonspecific initial presentation. In addition, a constant eye for these symptoms and a systematic approach to diagnosis are essential for prompt initiation of therapy and prevention of significant complications.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay